Clinical Trials Browser

Active not recruiting × OTHER × PM 01183 × Clear all

NCT04607954 2026-01-06

Durvalumab and Lurbinectedin for the Treatment of Relapsed or Refractory Small Cell Lung Cancer

Phase 2 Active not recruiting

Platinum-Resistant Lung Small Cell Carcinoma

NCT05099666 2025-12-09

Lurbinectedin + Doxorubicin In Leiomyosarcoma

Phase 1/2 Active not recruiting

Sarcoma